TNFRSF18 and colon adenocarcinoma: By studying the expression of Il9 in CT26 colon adenocarcinoma tumor-bearing mice treated with an agonistic anti-GITR antibody (DTA-1), Kim et al. found that the engagement of GITR was associated with strong IL-9 expression in the tumor-draining lymph nodes [31].